Concepedia

Publication | Open Access

The SOX9-MMS22L Axis Promotes Oxaliplatin Resistance in Colorectal Cancer

DOIFull Paper Access

15

Citations

21

References

2021

Year

Yiqiang Liu, Hong Wu, Tao Luo, Qiyu Luo, Ziyu Meng, Ying Shi, Feifei Li, Mingxin Liu, Xinhao Peng, Junjie Liu,
Frontiers in Molecular Biosciences

Abstract

In CRC, activation of the SOX9-MMS22L-dependent DNA damage pathway is a core pathway regulating oxaliplatin sensitivity. Targeting this pathway in oxaliplatin-resistant CRC cells is a promising therapeutic option.

References

YearCitations

Page 1